NFKB1 and stroke disorder: Additionally, cystatin C activates inflammatory pathways (e.g., NF-κB) and promotes the release of pro-inflammatory cytokines (e.g., IL-6, CRP), establishing a vicious cycle of post-stroke neuroinflammation and delayed neuronal death [41], significantly increasing all-cause mortality.